0 items USD 0.00Search
Your search for "marketline 3sbio inc mergers acquisitions ma partnerships alliances investment report" gave back 262076 results.
The global Biosimilar of Remicade market size was valued at US$ 292500 million in 2023. With growing demand in downstream market, the Biosimilar of...
Catalog:
LPI
February 2024
Price: USD 3,660.00
A biosimilar of Remicade is a biologic medication that is highly similar to the reference product, Remicade, in terms of safety, efficacy, and...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
The global Recombinant Protein Drug R & D market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
A biosimilar of Remicade is a biologic medication that is highly similar to the reference product, Remicade, in terms of safety, efficacy, and...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
The global Recombinant Protein Drug R & D market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The “Recombinant Protein Drug R & D Industry Forecast” looks at past sales and reviews total world Recombinant Protein Drug R & D sales in...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Market Analysis and Insights: Global Recombinant Protein Drug R & D Market The global Recombinant Protein Drug R & D market is projected to...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological...
Catalog:
MRRPB5
March 2023
Price: USD 4,900.00
NetApp Inc - Strategy, SWOT and Corporate Finance Report Summary NetApp Inc - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
August 2022
Price: USD 175.00
Fiserv, Inc. - Strategy, SWOT and Corporate Finance Report Summary Fiserv, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
November 2022
Price: USD 175.00
SS&C Technologies Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary SS&C Technologies Holdings Inc - Strategy, SWOT and...
MarketLine
March 2022
Price: USD 175.00
Novation Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Novation Companies, Inc. - Strategy, SWOT and Corporate Finance Report...
MarketLine
February 2020
Price: USD 175.00
